In February 2020 Reuters reported: “A study published in the New England Journal of Medicine last week reported a coronavirus patient in the United States was found to show an improvement after taking remdesivir, which is also used to treat infectious diseases such as Ebola.” This is a lie.
“The Safety Board pulled remdesivir from the [Ebola] study because it killed more people than any of the other three drugs,” Dr Bryan Ardis said, “remdesivir killed 54% of all the people that got the drug.” And, note that Reuters quoted a study which reported “a” – one – patient with coronavirus who had shown improvement after taking remdesivir.
Read the full article with the link below.
We spoke about this topic in the first part of this weeks podcast below.
